Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee | Johnson & Johnson

Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

02/26/2021

DownloadPDF 176 KB

Multimedia Files:

Questions? Please contact us:

investor-relations@its.jnj.com